ICD10monitor April 10, 2024
Federal officials this week announced the rollout of a Final Rule for Medicare Part D prescription drug plans and the rapidly expanding Medicare Advantage (MA) program for the 2025 contract year, heralding what they described as guidance to “build on existing CMS (Centers for Medicare & Medicaid Services) policies to promote competition, increase access to care, including important behavioral health services, and protect individuals from inappropriate marketing and prior authorization.”
“Competition within Medicare Advantage and Medicare Part D will provide consumers with meaningful choices among plans so they can select one that best meets their individual needs. Additional consumer protections will help people make the right decisions and get the coverage they want without hassles,” U.S. Department of Health and...
Today's Sponsors
Today's Sponsor